SCHEMBL2522774

SCHEMBL2522774

CC(C)=CCC/C(C)=C(\C)CO

nearest known ligand 0.52

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.52
MEN1 O00255 2/20 0.52
CYP3A4 P08684 2/20 0.52
ALOX15 P16050 2/20 0.52
MAPT P10636 2/20 0.50
ALDH1A1 P00352 2/20 0.50
UGT1A1 P22309 1/20 0.50
SQLE Q14534 5/20 0.48
TSHR P16473 1/20 0.44
KDM4E B2RXH2 2/20 0.41
ATM Q13315 1/20 0.41
POLB P06746 1/20 0.40
ICMT O60725 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26691679 1.00 KMT2A (0.52) KMT2AMEN1CYP3A4ALOX15MAPT
SCHEMBL13465734 0.91 KMT2A (0.67) KMT2AMEN1CYP3A4ALOX15MAPT
SCHEMBL29799108 0.91 KMT2A (0.67) KMT2AMEN1CYP3A4ALOX15MAPT
SCHEMBL25253071 0.91 KMT2A (0.67) KMT2AMEN1CYP3A4ALOX15MAPT
SCHEMBL25208155 0.91 KMT2A (0.67) KMT2AMEN1CYP3A4ALOX15MAPT
SCHEMBL6895251 0.80 KMT2A (0.48) KMT2AMEN1CYP3A4ALOX15MAPT
SCHEMBL27783831 0.80 KMT2A (0.48) KMT2AMEN1CYP3A4ALOX15MAPT
SCHEMBL8464166 0.78 KMT2A (0.55) KMT2AMEN1CYP3A4ALOX15MAPT
SCHEMBL19454910 0.77 KMT2A (0.48) KMT2AMEN1CYP3A4ALOX15MAPT
SCHEMBL15012806 0.75 KMT2A (0.43) KMT2AMEN1CYP3A4ALOX15MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12529077-B2 Production of geranyl diphosphate-derived compounds Københavns Universitet (DK) 2026-01-20 US claimed
CN-117396590-A Perfume for improving relaxation state and evaluation method 奇华顿股份有限公司 2024-01-12 CN claimed
EP-4279568-A1 THE USE OF A NON-CANONICAL TERPENES OR TERPENOIDS AS AROMA CHEMICALS BASF SE (DE) 2023-11-22 EP claimed
US-20230159960-A1 Production Of Geranyl Diphosphate-Derived Compounds KOBENHAVNS UNIVERSITET (DK) 2023-05-25 US claimed
EP-4133063-A1 PRODUCTION OF GERANYL DIPHOSPHATE-DERIVED COMPOUNDS Københavns Universitet (DK) 2023-02-15 EP claimed
CN-115698272-A Production of geranyl diphosphate derived compounds 哥本哈根大学 2023-02-03 CN claimed
EP-4279568-A1 THE USE OF A NON-CANONICAL TERPENES OR TERPENOIDS AS AROMA CHEMICALS BASF SE (DE) 2023-11-22 EP disclosed
US-8535883-B2 Methods of detecting sources of microorganism contamination BROWN UNIVERSITY (US) 2013-09-17 US disclosed
US-20110250604-A1 METHODS OF DETECTING SOURCES OF MICROORGANISM CONTAMINATION BROWN UNIVERSITY 2011-10-13 US disclosed
WO-2010033670-A1 METHODS OF DETECTING SOURCES OF MICROORGANISM CONTAMINATION BROWN UNIVERSITY (US) 2010-03-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12529077-B2 Production of geranyl diphosphate-derived compounds GGPS1, OGA, GBA3 KMT2A 3786/4885MEN1 4421/4885CYP3A4 224/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.